Glioblastoma Is the Most Aggressive Type Of Brain Cancer, With No Cure – CNS Pharmaceuticals’ Innovative Approach To Treatment Could Offer Hope - CNS Pharma (NASDAQ:CNSP)Glioblastoma Is the Most Aggressive Type Of Brain Cancer, With No Cure – CNS Pharmaceuticals’ Innovative - Benzinga

Glioblastoma is the most aggressive type of brain cancer, with an average survival of only 14 to 16 months after diagnosis. There is currently no cure for glioblastoma, and it is a highly invasive tumor that makes complete surgical removal difficult.